Combo Chemo With or Without Torisel Treating Rhabdomyosarcoma

To compare the EFS and the OS of patients with IR RMS treated with surgery , radiotherapy , and Vac alternating with VI(VAC/VI) to that of patients treated with surgery , radiotherapy and VAC/VI plus temsirolimus (TORI) To compare the outcome of patietns based on their FOXO1 fusioin gene partener by evaluating PAX3 vs PAX7 in all patients found to be FOXO1 fusion positive . To compare the outcome of patients based on their FDG-PET response at Week 9 ( positive or negative ) , as assessed by Deauville Criteria

September 20, 2016